Sign in

Alessio Ugolini

@alessiougolini.bsky.social
12 followers 10 following 2 posts

M.D., Ph.D. with a focus on Cancer Immunology Translational Research.

PostsRepliesMedia
Alessio Ugolini @alessiougolini.bsky.social · 08/10/2026
Our new paper is out in Neuro-Oncology! Targeting hypoxia-driven histone lactylation in myeloid cells synergizes with CD137 agonism to expand effector-like exhausted CD8+ T cells in glioblastoma academic.oup.com/neuro-oncolo...
academic.oup.com
Targeting hypoxia-driven histone lactylation in myeloid cells synergizes with CD137 agonism to expand effector-like exhausted CD8+ T cells in glioblastoma
AbstractBackground. Overwhelming presence of immunoregulatory myeloid cells and dysfunctional T cells is a major barrier to effective immunotherapies in gl
000
Alessio Ugolini @alessiougolini.bsky.social · 03/03/2025
I am thrilled to share that our latest work has been published on Cancer Discovery. In this manuscript, we provided a potential therapeutic strategy to counteract neutrophils-induced immunosuppression in cancer. doi.org/10.1158/2159...
doi.org
Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation
Abstract. Despite functional heterogeneity, high frequency of intratumoral neutrophils predicts poor clinical outcomes. The tumor microenvironment reprograms neutrophils into immunosuppressive subsets...
052